These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 21334338)
1. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Leise MD; Kim WR; Kremers WK; Larson JJ; Benson JT; Therneau TM Gastroenterology; 2011 Jun; 140(7):1952-60. PubMed ID: 21334338 [TBL] [Abstract][Full Text] [Related]
2. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845 [TBL] [Abstract][Full Text] [Related]
3. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185 [TBL] [Abstract][Full Text] [Related]
4. Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score. Beal EW; Akateh C; Tumin D; Bagante F; Black SM; Washburn K; Azouley D; Pawlik TM Exp Clin Transplant; 2020 Aug; 18(4):491-497. PubMed ID: 31050611 [TBL] [Abstract][Full Text] [Related]
5. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079 [TBL] [Abstract][Full Text] [Related]
7. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score. Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903 [TBL] [Abstract][Full Text] [Related]
8. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058 [TBL] [Abstract][Full Text] [Related]
9. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality. Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574 [TBL] [Abstract][Full Text] [Related]
10. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Barber K; Madden S; Allen J; Collett D; Neuberger J; Gimson A; Transplantation; 2011 Aug; 92(4):469-76. PubMed ID: 21775931 [TBL] [Abstract][Full Text] [Related]
11. Refitting the Model for End-Stage Liver Disease for the Eurotransplant Region. Goudsmit BFJ; Putter H; Tushuizen ME; Vogelaar S; Pirenne J; Alwayn IPJ; van Hoek B; Braat AE Hepatology; 2021 Jul; 74(1):351-363. PubMed ID: 33301607 [TBL] [Abstract][Full Text] [Related]
13. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality. Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024 [TBL] [Abstract][Full Text] [Related]
14. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil. Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC; Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694 [TBL] [Abstract][Full Text] [Related]
15. Wait-list mortality of young patients with Biliary atresia: Competing risk analysis of a eurotransplant registry-based cohort. van der Doef HPJ; van Rheenen PF; van Rosmalen M; Rogiers X; Verkade HJ; Liver Transpl; 2018 Jun; 24(6):810-819. PubMed ID: 29377411 [TBL] [Abstract][Full Text] [Related]
16. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Kwong AJ; Lai JC; Dodge JL; Roberts JP Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624 [TBL] [Abstract][Full Text] [Related]
17. Re-weighting the model for end-stage liver disease score components. Sharma P; Schaubel DE; Sima CS; Merion RM; Lok AS Gastroenterology; 2008 Nov; 135(5):1575-81. PubMed ID: 18835388 [TBL] [Abstract][Full Text] [Related]
18. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list. Myers RP; Tandon P; Ney M; Meeberg G; Faris P; Shaheen AA; Aspinall AI; Burak KW Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642 [TBL] [Abstract][Full Text] [Related]
19. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation. Wong RJ; Gish RG; Ahmed A Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379 [TBL] [Abstract][Full Text] [Related]
20. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. Myers RP; Shaheen AA; Faris P; Aspinall AI; Burak KW PLoS One; 2013; 8(1):e51926. PubMed ID: 23349678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]